A Discovery with Potential to Revitalize Hammerhead Ribozyme Therapeutics for Treatment of Inherited Retinal Degenerations
- PMID: 31884599
- PMCID: PMC7029959
- DOI: 10.1007/978-3-030-27378-1_20
A Discovery with Potential to Revitalize Hammerhead Ribozyme Therapeutics for Treatment of Inherited Retinal Degenerations
Abstract
Hammerhead ribozymes (hhRzs), RNA enzymes capable of site-specific cleavage of arbitrary target mRNAs, have faced significant hurdles in development and optimization as gene therapeutics for clinical translation. Chemical and biological barriers must be overcome to realize an effective therapeutic. A new Facilitated ribozyme has been identified with greatly enhanced kinetic properties that lead new insight on the capacity of ribozymes to target mutant genes to treat inherited retinal degenerations.
Keywords: Gene therapy; Hammerhead ribozyme; Inherited retinal degenerations; Noncoding RNA; RNA biologic therapies; Retinitis pigmentosa.
Figures
References
-
- Altman S (1990) Nobel lecture. Enzymatic cleavage of RNA by RNA. Biosci Rep 10(4):317–337 - PubMed
-
- Birikh KR, Heaton PA, and Eckstein F (1997) The structure, function and application of the hammerhead ribozyme. Eur J Biochem 245:1–16 - PubMed
-
- Bratty J Chartrand P, Ferbeyre G et al. (1993) The hammerhead RNA domain, a model ribozyme. Biochim Biophys Acta 1216:345–359 - PubMed
-
- Cech TR (1990) Nobel lecture. Self-splicing and enzymatic activity of an intervening sequence RNA from Tetrahymena. Biosci. Rep 10(3):239–261 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
